With Ass-1 KO mice, Ass-1silence BECs and Ass-1 inhibitor, via in vivo and in vitro experiments, we testified the hypothesis and proved that LA playing the protective effect on COPD was via inhibition of ROS/NLRP3/NF-κB pathway. Here, NFKB1 is linked to chronic obstructive pulmonary disease.